Skip to main content
Premium Trial:

Request an Annual Quote

Ionian Gets $2.7M DARPA Contract to Develop Hand-Held Biodetectors

NEW YORK, March 25 (GenomeWeb News) - Ionian Technologies has received a $2.7 million contract from the DoD's Defense Advanced Research Projects Agency to develop hand-held rapid detectors of biological agents, the company said yesterday.

 

Ionian, located in Upland, Calif., will develop assays and chemistry based on a DNA detection technology, Expar, that it licenses from the Keck Graduate Institute in Claremont, Calif., a subcontractor for the project.

 

Expar allows researchers to amplify nucleic acids isothermally and rapidly.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.